Scroll To Top
Search by Speciality

Molecular Analysis for Personalised (MAP) Therapy 2017

Swissotel Zurich | Zurich, SWITZERLAND
From 150 to 450 EUR
Event Preview
This event
is Finished
Title: Molecular Analysis for Personalised (MAP) Therapy 2017
Specialty: Internal Medicine
Dates: From Oct, 13, 2017 to Oct, 14, 2017
Location: Zurich, SWITZERLAND
Type: Course
Registration Cost: From 150 to 450 EUR
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for Zurich, Switzerland.
General Info
Event Venue:

Swissotel Zurich

Zurich, SWITZERLAND Visit the Venue to read more
Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

We are pleased to announce the 3rd edition of the Molecular Analysis for Personalised therapy (MAP) meeting, to be held in Zurich, October 13-14 2017.

A joint initiative of Cancer Research UK, UNICANCER and ESMO, this conference will explore clinical interpretation of molecular tests for metastatic cancers.

The development of new biotechnologies has revolutionised the applications of personalised therapy in metastatic cancer. It is now possible to perform multigene sequencing for cancer patients, either in clinical trials, or in routine use.

Unfortunately, while the technologies are robust, the interpretations of these molecular analyses is still a matter of debate, and there is a need to understand which molecular alterations should be targeted in cancer patients.

We recently outlined the need for such a conference in Annals of Oncology:

"Regular consensus meeting and transparency of data reporting (both positive and negative) will likely form a vital component of research community efforts to share experience and inform the next generation of clinical trials… These efforts should optimally be done under the sponsorship of an international scientific society."

The MAP conference will equip clinicians and researchers to interpret clearly the molecular analyses of their patients.

Scientific presentations by international leaders will highlight the latest advances in the field of personalised medicine for cancer patients.

Genomic clinical cases will offer some real-life examples of clinical interpretation in this field of genetic science.

Roundtable discussions will allow participants to exchange on how to prioritise targets in cancer patients.

We hope to see you at this exciting conference, where we discuss this emerging topic in detail and offer oncologists practical solutions for clinical treatment.

MAP Founders and Scientific Board

Fabrice André


 Jean-Charles Soria



Charles Swanton



Andrea Alimonti,
Bellinzona, SUI

Hyman Photo

David Hyman,
New York, USA

Scarpa Photo

Aldo Scarpa,
Verona, ITA

Fabrice André,
Villejuif, FRA

Ahmed Idbaih

Ahmed Idbaih,
Paris, FRA

Dirk Schadendorf

Dirk Schadendorf,
Essen, GER

Jean-Yves Blay

Jean-Yves Blay,
Lyon, FRA

silouettte m

Aurélien Marabelle,
Villejuif, FRA

SORIA Jean Charles

Jean-Charles Soria,
Villejuif, France

Bernd Bodenmiller

Bernd Bodenmiller,
Zurich, SUI

Michiels Stefan

Stefan Michiels,
Villejuif, FRA

Soumelis Photomini

Vassili Soumelis,
Paris, FRA

Robert Bristow

Robert Bristow,
Toronto, CAN

Gary Middleton

Gary Middleton,
Birmingham, UK

Michael Speicher

Michael Speicher,
Graz, AUT

Registration Needs updating Register Now


Registration Cost
Early Registration

Late Registration From: 2017-08-16 To: 0--
On site Registration

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts


Swissotel Zurich

Schulstrasse 44

Zurich, Zurich, Switzerland

Scientific Content Up to Date
Submission Info

We invite you to consider presenting a Poster at MAP.

Poster presentations describing molecular alterations for clinical practice work in the following areas are welcome:

• Therapeutic targets in cancer

• Tumour microenvironment and treatment resistance

• New models and technologies for personalised medicine

• Treatment advances in central nervous system tumours

• Understanding the broader tumour microenvironment

• Macroevolution and impact on treatment resistance

• Personalised medicine applied to immunotherapeutics

At least one of the abstract authors must be present at the conference. 

All questions pertaining to the MAP poster submission should be directed to


The best abstracts from young oncologists (under 40 years old) will be selected for oral presentation.


A restricted number of travel grants for MAP 2017 are available, upon application, to first author (the presenter) of candidates under the age of 40 who submit abstracts considered deserving of recognition. Selection will be made by the MAP 2017 Scientific Committee on a competitive basis from among the accepted abstracts.

To apply for a travel grant, the following documents must be received by the MAP Conference secretariat ( on or before August 4, 2017:

1. A letter of introduction by the applicant. Please include the following general information:

            •  How relevant are the topics presented during the MAP conference to your current practice and research?

            •  Have you attended any event on a similar topic in the last 3 years? 

            •  How do you believe your attendance at the MAP conference will help you improve your knowledge in the field and your professional development? 

            •  How do you consider that the findings published in your abstract make a relevant contribution to the topics presented during this conference? 

            •  Have you previously been awarded a MAP travel grant? If yes, when?

2. A copy of the submitted abstract (the applicant must be the first author and presenter) 

3. A readable photocopy of either identity card or passport 

4. A short curriculum vitae (maximum 2 pages)

Documentation must be sent by e-mail to

The MAP 2017 organisers will provide the recipients of this travel grant with congress registration, two nights accommodation and a limited travel stipend.

Travel grant recipients must submit a report detailing the benefits of participating in MAP 2017 by November 12, 2017.

Incomplete applications will not be considered.


Accepted abstracts will be edited in the "Annals of Oncology" journal.


The abstract must not exceed 500 words, and should be organized as follows:

           • Title

           • Author(S)

           • Background

           • Methods

           • Results

           • Conclusions

           • Clinical trial identification (if applicable)

           • Legal entity responsible for the study

           • Funding

           • Disclosure (for all listed authors)


Authors’ full names and affiliations must be specified; surnames should be in capital letters. 

All abstracts should be submitted in English.


A maximum of TWO abstracts from a presenter will be considered.

The scientific committee.



Deadline for submissions : August 4, 2017.

Sponsors Exhibitors
General Info

The organisers gratefully acknowledge the following companies and institutions 

for their financial support of the MAP 2016 conference.

Contact No.: +33 (0)1 41 92 01 27


Organising Agency

Contact No.: +33 (0)1 41 92 01 27


Official Event Webpage
Event map
Revelant Events